Multiple myeloma without initial paraproteins.
D000328:Adult; D001536:Bence Jones Protein / Q000652:urine; D001797:Blood Protein Electrophoresis; D001856:Bone Marrow Examination; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005459:Fluorides / Q000627:therapeutic use; D006801:Humans; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy; D009194:Myeloma Proteins / Q000097:blood* / Q000652:urine; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D009194:Myeloma Proteins; D009607:Nitrosourea Compounds; D003520:Cyclophosphamide; D001536:Bence Jones Protein; D008558:Melphalan; D005459:Fluorides; D011241:Prednisone